Mission: Mission: Our mission is to discover new ways to improve and extend people`s lives. Our vision is to be a trusted leader in changing the practice of medicine. www.novartis.com
One job. Two associates: ’Our job share enables us to be successful together, while giving us more time with our families.’ Hear Robert and Stefan’s story. http://glassdoor.com/slink.htm?key=vQ32I
We have a history of firsts, and there’s more to come. Join us in 2019 and be a part of the journey. http://glassdoor.com/slink.htm?key=vQOmM
That’s how many lives our products touched in 2017.
200 projects currently in clinical development. 16 major approvals last year alone. These are achievements we’re incredibly proud of, but in this world of digital and technological transformation, we must also ask ourselves this: how can we continue to improve and extend even more people’s lives?
Novartis focuses on innovative patent-protected medicines, generics and eye care products – segments where we have global reach and strong relations with our customers. Research and development (R&D) sits at the core of our business and central to our strategy. Our global organizations for manufacturing, business services and other functions help increase efficiency and promote excellence.
The Innovative Medicines division has two business units:
Novartis Pharmaceuticals focuses on patented treatments in the areas of cardiovascular, respiratory, neuroscience, ophthalmology, and immunology and dermatology.
Novartis Oncology is focused on treatments for a variety of cancers and rare diseases.
Sandoz : Sandoz offers patients and healthcare professionals high-quality, affordable generics and biosimilars. The Sandoz portfolio also includes some mature products that were transferred from the Innovative Medicines division in 2016.
Alcon: With its Surgical and Vision Care businesses, Alcon offers one of the world’s widest selections of eye care devices – from sophisticated equipment for delicate eye surgery to a wide portfolio of advanced contact lenses.
Functional organizations with a global reach:
Novartis Institutes for BioMedical Research (NIBR): NIBR focuses on discovering new drugs that can change the practice of medicine.
Global Drug Development (GDD): GDD oversees the development of new medicines.
Novartis Technical Operations (NTO) is responsible for our global production unit
Novartis Business Services (NBS) focuses on internal services.
23,000 associates, 24 sites and 4 key campuses.
Our US presence extends from coast-to-coast with our campuses designed to foster a world-class work environment, and promote a culture of collaboration and innovation to help continually meet the evolving needs of our patients, customers and the communities we serve.
Research in the United States
We know our medicines can have a dramatic impact on patients’ lives. They can help people live longer and remain healthier, and they can provide significant benefits to our society and economy, which is why in 2017 we invested $3.4 Billion in R&D alone.
Reimagining Medicine through Innovation
Innovation is a cornerstone of the Novartis strategy and a foundation of our future. Research and development (R&D) as well as a strong pipeline of potential medicines are critical for our future business and long-term success.
The Novartis Institutes for BioMedical Research (NIBR) is the innovation engine of Novartis. With a US team of scientists, physicians and business professionals, NIBR works to discover potential new therapies that could improve health outcomes for patients; and works in concert with our Global Drug Development (GDD) group to bring innovative treatments to patients around the world. Of the 6,800 employees working in R&D in the US, 2,500 work at our Research and Early Development Headquarters at NIBR in Cambridge.
Corporate responsibility is endorsed and ingrained at the highest level of Novartis and is central to how we run our business.
We are inspired by helping patients and the communities where we live and work. This not only includes our day-to-day efforts as we develop and make available innovative medicines, but also how we give back through volunteering, charitable giving, and patient assistance programs.
Expanding Access to Healthcare: Developing new and innovative ways to reach people in lower-income countries is one of our top priorities. To expand access to healthcare, we pursue a variety of approaches.
Doing Business Responsibly: We recognize that achieving our business goals requires that we operate with high integrity, transparency and environmental sustainability.
Corporate Responsibility Report: Novartis has a strong history of corporate responsibility activities, and transparent reporting is a central part of our commitment.
In the US:
Novartis Commitment to the Environment
Novartis is committed to building a sustainable future with ongoing initiatives and programs designed to conserve, protect and recycle. Our East Hanover campus is home to a series of conservation initiatives designed to educate and assist with energy efficiency.
That’s how many lives our products touched in 2017. 200 projects currently in clinical development. 16 major approvals last year alone. These are achievements we’re incredibly proud of, but in this world of digital and technological transformation, we must also ask ourselves this: how can we continue to improve and extend even more people’s lives?
We believe the answers are found when curious, courageous and collaborative people like you are brought together in an inspiring environment. Where you’re given the opportunity to explore the power and potential of data and digital. Where you’re empowered to risk failure by taking smart risks. Where you’re encouraged to share new ideas that can open up new ways of making things happen. And where you’re surrounded by teams who are equally determined to transform lives by tackling the world’s toughest medical challenges.
With people from so many nations working at Novartis, we have a richly multicultural working environment.
While our diverse workforce brings different people and perspectives together, inclusion is making the mix work. It is about creating an atmosphere and an environment where each of us feels valued, respected and heard.
3,164 associates are part of 15 employee resource groups at Novartis in the US which includes:
I worked at Novartis full-time (More than 10 years)
Great place to work and grow. The company invest a lot in your training to make you better.
No real cons, the company was a great place to work.
Advice to Management
Why not bring back some if the old talent you invested so much in? After all they were the driving force behind the companies success. So much was invested in your employees and many were let go, why nor get done if that investment back and hire some of these people back?
I applied through an employee referral. The process took 6 weeks. I interviewed at Novartis (East Hanover, NJ) in October 2010.
First phone interview, mainly on your experience and skill sets, talk about the projects you did.
Then on-site interview with panel staff. It is also required to take drug test and background check. The whole process took about 6 weeks.